Kenza Health Hub logoGet Started
1 May 2026Injectable drugs

Benzathine benzylpenicillin injectable

Long-acting benzathine benzylpenicillin guidance for syphilis, endemic treponematoses, tonsillitis, and rheumatic-fever prophylaxis.

Prescription under medical supervision
This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Therapeutic action

Long-acting penicillin antibacterial.

Indications

  • Early and late latent syphilis.
  • Congenital syphilis without clinical signs in the neonate and adequate treatment in the mother.
  • Endemic treponematoses such as yaws, bejel, and pinta.
  • Streptococcal tonsillitis, prophylaxis of diphtheria, and primary and secondary prophylaxis of rheumatic fever.

Forms and strengths, route of administration

  • Powder for injection in 1.2 MIU vial and 2.4 MIU vial, for IM injection only.
  • Never for IV injection or infusion.

Dose

Syphilis

  • Child: 50,000 IU/kg per injection, maximum 2.4 MIU per injection.
  • Adult: 2.4 MIU per injection.

Yaws, bejel, pinta

  • Child under 10 years: 1.2 MIU per injection.
  • Child 10 years and over and adult: 2.4 MIU per injection.

Streptococcal tonsillitis, prophylaxis of diphtheria, prophylaxis of rheumatic fever

  • Child under 30 kg: 600,000 IU per injection.
  • Child 30 kg and over and adult: 1.2 MIU per injection.

Duration

  • Early syphilis, congenital syphilis, tonsillitis, yaws, bejel, pinta, prophylaxis of diphtheria, primary prophylaxis of rheumatic fever: single dose.
  • Late latent syphilis: one injection weekly for 3 weeks.
  • Secondary prophylaxis of rheumatic fever: one injection every 4 weeks for several years.

Contra-indications, adverse effects, precautions

  • Once reconstituted, suspension must be used immediately.
  • Do not administer to penicillin-allergic patients.
  • Administer with caution to patients allergic to cephalosporins and to patients with renal impairment.
  • May cause gastrointestinal disturbances, pain at injection site, allergic reactions, Jarisch-Herxheimer reaction, convulsions in renal impairment or high doses, and symptoms of shock in case of accidental IV injection.
  • Ensure that the IM injection does not enter a blood vessel.
  • Do not combine with methotrexate.
  • Pregnancy and breast-feeding: no contra-indication.
  • Do not confuse long-acting benzathine benzylpenicillin for IM use with rapidly acting benzylpenicillin administered by IV route.
  • Do not mix with other drugs in the same syringe.

Source

MSF Essential drugs practical guidelines (January 2026)

This page reproduces the structured reference information for this batch while leaving out the Storage and Remarks sections.

Rate this guide

Be the first to rate this guide.